Skip to content

Mitch Earleywine

Albany State University, University at Albany, State University of New York

36 papers in the library · 456 citations · publishing 2001-2026

Papers

Sort Most recent Most cited

Symptom specificity of ayahuasca's effect on depressive symptoms

Journal of Psychedelic Studies April 19, 2021 Cody Gilbert, Mitch Earleywine, Maha N. Mian et al. 3 citations

Abstract Background Ayahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew. Aims We examined self-reported effects of ayahuasca on the individual symptoms of depression...

Cannabis-induced oceanic boundlessness

Journal of Psychopharmacology March 28, 2021 Mitch Earleywine, Luna F. Ueno, Maha N. Mian et al. 36 citations

Background: Despite tetrahydrocannabinol (THC)’s reputation for creating dramatic effects at high doses, empirical work rarely addresses cannabis’s impact on subjective responses common to the tryptamine psychedelics. We focused on these effects because they have preceded and covaried with the therapeutic impact of psilocybin in previous work. Aims: The current study examined if self-reported...

Psychedelic-assisted psychotherapy for depression: How dire is the need? How could we do it?

Journal of Psychedelic Studies June 1, 2020 Mitch Earleywine, Joseph A. de Leo 12 citations

Abstract Despite the popular support for psychedelics as aids for depression, academics and the public frequently overestimate the efficacy of available medications and psychotherapies. Metaanalyses reveal that antidepressant medications alone help only one in four patients and rarely surpass credible placebos. Their effects, though statistically significant, might not impress depressed...

The Novelty of Ayahuasca Scale and the prediction of intentions to use

Journal of Psychedelic Studies March 12, 2020 Brianna R. Altman, Maha N. Mian, Mitch Earleywine 4 citations

Abstract Objective Given the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin. Method Experienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca...

Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness

Journal of Psychoactive Drugs September 30, 2019 Maha N. Mian, Brianna R. Altman, Mitch Earleywine 47 citations

Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and...

Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis

Journal of Psychoactive Drugs July 29, 2019 Stacey Farmer, Melissa N. Slavin, Mallory Loflin et al. 16 citations

Cannabis remains the most frequently used illicit drug in the United States. As its legal status has changed, more people have turned to oral administration (“edibles”). 172 individuals who reported an uncomfortable experience with edible cannabis completed an online survey. Despite the aversive nature of the experience, 62.9% of the sample reported that the edible experience was at least...

Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay

Journal of Psychoactive Drugs August 3, 2017 Mallory Loflin, Mitch Earleywine, Stacey Farmer et al. 7 citations

Previous research has demonstrated the ability of non-active smoked cannabis cigarettes to induce subjective effects of intoxication (i.e., placebo effect). No studies have been conduced to test whether edible forms of cannabis, which are associated with a significant delay in onset of effect, are able to induce a placebo effect. In the present study, 20 participants were told that they would...

Polydrug use, cannabis, and psychosis‐like symptoms

Human Psychopharmacology: Clinical and Experimental August 1, 2008 Nicholas T. van Dam, Mitch Earleywine, Greg DiGiacomo

AbstractObjectiveTo examine psychosis‐like symptoms in users of legal and illicit drugs.MethodsSchizotypal Personality Questionnaire (SPQ) scores were compared in groups of people with different exposure to cannabis, with the use of other drugs serving as a covariate. Supplemental analyses compared users of legal and illicit drugs with cannabis use as a covariate.ResultsWeekly (n = 111) and...

Cannabis, motivation, and life satisfaction in an internet sample

Substance Abuse Treatment, Prevention, and Policy January 12, 2006 Sara Smucker Barnwell, Mitch Earleywine, Rand R. Wilcox 69 citations

Although little evidence supports cannabis-induced amotivational syndrome, sources continue to assert that the drug saps motivation 1, which may guide current prohibitions. Few studies report low motivation in chronic users; another reveals that they have higher subjective wellbeing. To assess differences in motivation and subjective wellbeing, we used a large sample (N = 487) and strict...

DOI: 10.1186/1747-597x-1-2 (opens in new tab) Normality Abstinence Clinical psychology Cannabis dependence +2

THE CANNABIS AND PSYCHOSIS CONNECTION QUESTIONED: A COMMENT ON FERGUSSON ET AL. 2005

Addiction April 22, 2005 B Mirken, Mitch Earleywine 10 citations

Fergusson and colleagues assert that their results from a New Zealand cohort ‘add to the growing body of evidence that regular cannabis use may increase risks of psychosis’[1]. In fact, their study raises more questions than it answers. One obvious question is raised by their use of ten items from Symptom Checklist 90 as the only assessment tool for symptoms of psychosis. The items assessed...

Cannabis‐induced Koro in Americans

Addiction November 1, 2001 Mitch Earleywine 57 citations

AIMS: Koro, an acute panic reaction related to the perception of penile retraction, was once considered limited to specific cultures. The disorder has appeared as part of a panic response to cannabis, but only in citizens of India. This study looked for cannabis-induced Koro in Americans. DESIGN: Given the relative rarity of cannabis-induced Koro, this work focused on individual case studies....